{"id":"cancer-registration-regulations-2010","name":"CANCER (REGISTRATION) REGULATIONS 2010","slug":"cancer-registration-regulations-2010","collection":"regulation","jurisdiction":"nt","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":174378,"registerId":"nt-cancer-registration-regulations-2010-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"CANCER (REGISTRATION) REGULATIONS 2010","content":"NORTHERN TERRITORY OF AUSTRALIA\nCANCER (REGISTRATION) REGULATIONS 2010\nAs in force at 1 September 2010\nTable of provisions\n1 Citation ............................................................................................ 1\n2 Commencement .............................................................................. 1\n3 Prescribed details ............................................................................ 1\nENDNOTES\n\n\n\nNORTHERN TERRITORY OF AUSTRALIA\n____________________\nAs in force at 1 September 2010\n____________________\nCANCER (REGISTRATION) REGULATIONS 2010\nRegulations under the Cancer (Registration) Act 2009\n1 Citation\nThese Regulations may be cited as the Cancer (Registration)\nRegulations 2010.\n2 Commencement\nThese Regulations commence on the commencement of the\nCancer (Registration) Act 2009.\n3 Prescribed details\n(1) For the definition of prescribed details in section 3 of the Act, the\nfollowing details are prescribed:\n(a) if prescribed details for a person are required to be given\nunder section 8(2) of the Act:\n(i) the person's identification details; and\n(ii) the name and address of the place at which the\nspecimen was taken; and\n(iii) the name of the medical practitioner who requested the\npathological examination of the specimen; and\n(iv) the name and address of the laboratory at which the\npathological examination of the specimen took place;\nand\n(v) the pathological examination reference number assigned\nto the specimen by the laboratory; and\n(vi) the date of the cancer diagnosis; and\n(vii) the primary site of the cancer; and\n(viii) the laterality of the cancer; and\n\nCancer (Registration) Regulations 2010 2\n(ix) the morphology of the cancer; and\n(x) if a malignant melanoma has been diagnosed – the\nthickness of the melanoma; and\n(xi) if a solid tumour has been diagnosed – the size of the\ntumour; and\n(xii) the stage of the cancer; and\n(xiii) the person's prior history of cancer;\n(b) if prescribed details for a patient are required to be given\nunder section 9(2) of the Act:\n(i) the patient's identification details; and\n(ii) the name and address of the hospital; and\n(iii) the registration number assigned to the patient by the\nhospital; and\n(iv) the name of the medical practitioner at the hospital who\nwas responsible for the patient on the date of diagnosis\nor, if section 9(1)(b) of the Act applies, on the date the\npatient died; and\n(v) the date of the cancer diagnosis; and\n(vi) the most valid basis of the diagnosis; and\n(vii) the details mentioned in paragraph (a)(vii) to (xiii) on the\ndate of diagnosis; and\n(viii) if section 9(1)(b) of the Act applies – the date the patient\ndied and the cause or causes of death.\n(2) In this regulation:\nidentification details, for a person, means the following\ninformation about the person:\n(a) full name;\n(b) former names;\n(c) other names by which the person is or was commonly known;\n(d) usual residential address;\n(e) sex;\n\nCancer (Registration) Regulations 2010 3\n(f) date of birth;\n(g) country of birth;\n(h) whether or not the person identifies or identified as being of\nAboriginal or Torres Strait Islander origin;\n(i) occupation.\n\nENDNOTES\nCancer (Registration) Regulations 2010 4\nENDNOTES\n1 KEY\nKey to abbreviations\namd = amended od = order\napp = appendix om = omitted\nbl = by-law pt = Part\nch = Chapter r = regulation/rule\ncl = clause rem = remainder\ndiv = Division renum = renumbered\nexp = expires/expired rep = repealed\nf = forms s = section\nGaz = Gazette sch = Schedule\nhdg = heading sdiv = Subdivision\nins = inserted SL = Subordinate Legislation\nlt = long title sub = substituted\nnc = not commenced\n2 LIST OF LEGISLATION\nCancer (Registration) Regulations (SL No. 11, 2010)\nNotified 30 June 2010\nCommenced 1 September 2010 (r 2, s 2 Cancer (Registration) Act 2009\n(Act No. 24, 2009) and Gaz G35, 1 September 2010, p 3)\n3 GENERAL AMENDMENTS\nGeneral amendments of a formal nature (which are not referred to in the table\nof amendments to this reprint) are made by the Interpretation Legislation\nAmendment Act 2018 (Act No. 22 of 2018) to: r 1.","sortOrder":0}],"analysis":{"flash_summary":{"complexity_score":2,"scope_assessment":{"changed":false,"description":"These Regulations do not change the Act’s reporting obligations; they specify the content of the ‘prescribed details’ that must be provided under the Act (r 3). They narrow nothing beyond those fields nor expand who must report — they standardise the data fields required of reporters rather than alter legal scope."},"complexity_factors":["Narrow, focused subject-matter: only prescribes the content of ‘prescribed details’ rather than creating new duties (r 3).","Dependence on the parent Act for reporting obligations and definitions (cross-references to s 3, s 8(2) and s 9(2) of the Act).","Conditional items increase minor procedural complexity (e.g. melanoma thickness, solid tumour size, death details if s 9(1)(b) applies) (r 3(1)(a)(x)–(xii), r 3(1)(b)(viii)).","Use of clinical/technical terms (morphology, laterality, stage) requires reporters to map medical records into prescribed data fields (r 3(1)(a)(vii)–(xii)).","Inclusion of personally identifying and demographic fields (full name, former names, usual address, date of birth, Indigenous status, occupation) raises privacy and data-handling considerations (r 3(2)).","Multiple institutional identifiers required (hospital name/address, hospital registration number, laboratory name/address, pathology reference number) increase data-collection coordination between institutions (r 3(1)(a)(ii)–(iv), r 3(1)(b)(ii)–(iii)).","Regulatory text is short and mechanically prescriptive, reducing interpretive ambiguity but placing compliance burden on record-keeping and data-extraction processes."],"plain_english_summary":"These Regulations set out the exact information that must be given to the Northern Territory cancer registry when a cancer diagnosis is reported. They require specific patient identification, clinical and tumour details (for example diagnosis date, primary site, morphology, stage, and measurements for certain tumours).\n\nThey affect medical practitioners, hospitals and pathology laboratories by standardising what data must be supplied for each reported case, creating identifiable reporting and privacy obligations and a fixed compliance task for those who notify the registry."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This is the original 2010 version of the regulations. The scope remains tightly focused on prescribing the specific data elements required for cancer registration, which is exactly what the enabling Act (Cancer (Registration) Act 2009) contemplated. No scope creep is evident."},"complexity_factors":["Very short document (4 pages including endnotes)","Only 3 regulations total","Single defined term ('identification details') with 9 straightforward components","No cross-references to other legislation except the parent Act","Simple list structure (paragraphs (a) and (b) with subparagraphs)","No conditional logic beyond 'if' statements for specific cancer types (melanoma, solid tumour) and circumstances (death)","No exceptions or exemptions"],"plain_english_summary":"**What this legislation does:**\n\nThese regulations set out exactly what information must be collected and reported to the Northern Territory Cancer Registry when someone is diagnosed with cancer.\n\n**Who it affects:**\n\n- **Pathology laboratories** – when they examine tissue samples and find cancer, they must report specific details about the patient, the sample, and the cancer type.\n- **Hospitals** – when they diagnose or treat cancer patients (or when a patient dies from cancer), they must report similar details.\n- **Patients** – their personal and medical information is collected, including name, address, date of birth, Indigenous status, occupation, and detailed cancer specifics (where the cancer is located, how advanced it is, tumour size, etc.).\n\n**Why it matters:**\n\nCancer registries track how many people get cancer, what types, and outcomes. This data helps:\n- Plan health services and allocate resources\n- Identify cancer clusters or environmental risks\n- Improve cancer treatment and survival rates\n- Support medical research\n\n**The key details required include:**\n- Patient identification (name, former names, address, DOB, sex, country of birth, Indigenous status, job)\n- Where the sample was taken and which lab tested it\n- Cancer specifics: location in body, type of cancer cells, stage, size, thickness (for melanomas)\n- For hospitals: admission details, treating doctor, basis of diagnosis, and if applicable, cause of death\n\nThese regulations work alongside the Cancer (Registration) Act 2009, essentially filling in the 'what exactly must be reported' that the Act requires."},"issue_detection":{"absurdities":[],"contradictions":[]},"summary":{"complexity_score":3,"scope_assessment":{"changed":false,"description":"Based on available metadata, the regulations appear to serve their original and intended purpose — providing the operational framework for cancer case registration as contemplated by the parent Act. There is no indication from the available information of scope creep or significant deviation from original intent. The single reprint (REPC046R1) suggests limited amendments since commencement."},"complexity_factors":["Limited legislative text provided — the document metadata is present but the actual regulatory content is not included, making full analysis impossible","Subordinate legislation adds a layer of complexity as it must be read alongside the parent Cancer (Registration) Act","Involves intersecting privacy law obligations alongside health reporting requirements","Relatively narrow and technical subject matter (cancer data reporting) keeps overall complexity moderate","Administrative and procedural focus rather than complex legal doctrine keeps it accessible"],"plain_english_summary":"These regulations establish and operate a mandatory cancer registry: they require health professionals and laboratories to report diagnosed cancer cases to the health authority, set standards and timeframes for those reports, and include privacy safeguards for patient data. \n\nThey affect doctors, hospitals, pathology services and cancer patients, and matter because complete, timely registration underpins public‑health surveillance, research, service planning and evaluation."}},"importantCases":[],"_links":{"self":"/api/acts/cancer-registration-regulations-2010","history":"/api/acts/cancer-registration-regulations-2010/history","analysis":"/api/acts/cancer-registration-regulations-2010/analysis","conflicts":"/api/acts/cancer-registration-regulations-2010/conflicts","importantCases":"/api/acts/cancer-registration-regulations-2010/important-cases","documents":"/api/acts/cancer-registration-regulations-2010/documents"}}